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Abstract
Drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are a
target for new antimicrobial technologies. Far-UVC technology is an emerging disinfection
method that directly kills microorganisms using light. In contrast with conventional UV sterili-
zation, far-UVC light has antimicrobial capabilities without apparent harm to mammalian
cells. This study examines the application of 224 nm far-UVC light delivered from a laser
using an optical diffuser towards the goal of protecting against bacterial invasion around
skin penetrating devices. Delivery of far-UVC using a laser and optical fibers enables expo-
sure to unique geometries that would otherwise be shielded when using a lamp. Testing of
the bactericidal potential of diffusing the far-UVC laser output over a large area was tested
and yielded qualitative area killing results. The killing of MRSA using this method was also
examined using an in vitro survival assay. Results followed a classic log-linear disinfection
model with a rate constant of k = 0.51 cm2/mJ, which corresponds to an inactivation cross
section of D90 = 4.5 mJ/cm2. This study establishes far-UVC delivered from a laser through
an optical diffuser as a viable solution for disinfection of susceptible regions such as around
catheters, drivelines, or other skin penetrating medical devices.
Introduction
Infections from drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus
(MRSA) present major health care challenges with over 23,000 cases resulting in death in the
United States each year [1]. Fighting these infections is a strain on limited healthcare resources
considering the average length of a hospital stay is estimated at more than 11 days longer for
infected individuals than those without infection [2]. Substantial financial burdens are also a
consequence, with estimated associated costs in the US approaching $10 billion annually [3].
While significant resources have been applied to combat infection from drug-resistant bacte-
ria, and incremental gains have been reported, effective resolutions remain elusive.
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One method of microbial disinfection is using ultraviolet (UV) light, conventionally using
low-pressure mercury lamps emitting primarily at 254 nm. UV light at 254 nm can efficiently
kill both drug-sensitive and multi-drug-resistant bacteria [4], as well differing strains of viruses
[5]. However, the widespread use of germicidal ultraviolet light has been very limited because
conventional UVC light sources are a human health hazard, being both carcinogenic and quite
damaging to eye tissue [6, 7].
By contrast, it has been shown that far-UVC light generated by filtered excimer lamps emit-
ting in the 207 to 222 nm wavelength range, efficiently kills drug-resistant bacteria, without
apparent harm to exposed mammalian skin [8–11]. The biophysical reason is that, due to its
strong absorbance in biological materials, far-UVC light does not have sufficient range to pen-
etrate through even the outer layer (stratum corneum) on the surface of human skin, nor the
outer tear layer on the outer surface of the eye, neither of which contain living cells; however,
because bacteria and viruses are typically of micron or smaller dimensions, far-UVC light can
still efficiently traverse and inactivate them [8–10]. Furthermore, recent work has shown that
irradiation of an open wound, which did not have a protective layer of stratum corneum, with
222 nm light did not induce DNA damage in targeted cells while still showing bactericidal con-
trol [11].
Adventitious infections due to pathogens such as MRSA are especially prominent within
wounds surrounding catheters, drivelines for left ventricular assist devices, and lines for hemo-
dialysis [12–14]. In these cases, a far-UVC light source such as an excimer lamp would not be
sufficient for disinfection because the implanted lines would act as shielding for much of the
wound. Additionally, the far-UVC light cannot penetrate the skin to disinfect within the
wound. One possible solution to these situations is to direct light around and within complex
geometries using fiber optics. The fiber optics, which can be coupled with a far-UVC laser as a
source of light, could be manipulated to deliver light to multiple locations around an area
prone to infection. Pairing the fiber optic with a diffusing element capable of emitting the light
radially from the fiber would allow for application over a large target area within the percuta-
neous site that would be impossible to expose otherwise.
This study examines the use of far-UVC light generated from a laser source to be delivered
via fiber optics to an optical diffuser element for bactericidal applications. These studies are
performed in vitro as a first step to demonstrate the efficacy of this method. The development
of this new technique to reduce infection at skin entry sites while also being potentially safe for
human exposure is significant for the fight against drug-resistant bacteria, particularly in hos-
pital settings.
Materials and methods
Far-UVC source and diffuser
The far-UVC laser module (He-Ag 70-224SL, Photon Systems, Covina, CA) used in this study
emits at 224 nm and operates in a pulsed output mode. The laser was set to run with a buss
voltage of 420 V, 15 A of current, a pulse width of 100 μs, and a pulse frequency of 20 Hz. A
laser to multimode fiber coupler (HPUC-25-225-M-10BQ-2, Oz Optics, Ottawa, Ontario,
Canada) with an f = 10 mm biconvex lens reduced the 3 mm output beam diameter into a
400 μm/440 μm/480 μm (core/cladding/coating) solarization resistant fiber with a diffuser on
the distal end (Molex, Phoenix, AZ). The fiber has a numerical aperture of 0.22 and a length of
approximately 1 meter. The cylindrical diffuser is made of fused silica which has been
inscribed with micro-grooves using a laser and measures 1 mm in diameter and 5 cm long.
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Far-UVC dosimetry
Measurement of far-UVC exposure was performed using our previously published methods
utilizing UVC sensitive film [15, 16]. This method was chosen because commercially available
UV power meters, which usually integrate power over a single photodiode, do not measure the
spatial power distribution with sufficient accuracy to characterize the unique power output of
the optical diffuser. The film from Ashland Specialty Ingredients (Bridgewater, NJ) is referred
to as unlaminated Gafchromic EBT3 (Product Code 849952). This specialty film is essentially
one half of the regular Gafchromic EBT3 film; it is simply a 14 μm thick active layer on top of a
125 μm polyester substrate. The active layer contains a proprietary mixture of active material,
marker dye, stabilizers, and other components. In our previous work, we reported on the util-
ity of this film for UV exposure measurement [15]. The film showed a response to exposures
from wavelengths ranging from 207 nm to 328 nm and exhibited a dynamic range extending
up to as high as 100 mJ/cm2. The film is extremely sensitive, with radiant exposures in the
range of μJ/cm2 detectable for 222 nm light. Our previous work also showed that the film has a
wavelength dependent response thus it is important to calibrate with a source emitting a spec-
trum that closely matches the analyzed light source. The film has a high spatial resolution with
the ability to resolve features to at least 25 μm. The polyester layer is blocking to UV radiation
so the active region must be oriented towards the source for accurate measurement. When the
film is radiated on the side with the active region it exhibits a nearly ideal cosine response like
other radiochromic films [17, 18].
Calibration of the UV sensitive film was performed through a series of exposures using an
excimer lamp (High Current Electronics Institute, Tomsk, Russia) with a krypton-chlorine
(Kr-Cl) gas mixture emitting principally at 222 nm. A custom bandpass filter (224NB7, Omega
Optical, Brattleboro, VT), CWL of 222þ2
  1
nm and FWHM of 7þ2
  1
nm, was used with the Kr-Cl
lamp to isolate the 222 nm peak [19]. The film response between the calibration wavelength of
222 nm and the measured wavelength of 224 nm from the laser is not significantly different
thus this calibration is appropriate [15]. Optical power measurements for the calibration were
performed using an 818-UV/DB low-power UV enhanced silicon photodetector with an
843-R optical power meter (Newport, Irvine, CA). A range of radiant exposures, from 3.6 μJ/
cm2 up to 281.6 mJ/cm2, were performed on the film to define a response curve. Films were
scanned as 48 bit RGB TIFF images at 150 dpi using an Epson Perfection V700 Photo flatbed
scanner (Epson, Suwa, NGN, Japan) and analyzed with radiochromic film analysis software
(radiochromic.com) [20] to calculate the total exposure based on measured changes in optical
density.
MRSA preparation
We used methicillin-resistant S. aureus (MRSA USA300, multilocus sequence type 8, clonal
complex 8, staphylococcal cassette chromosome mec type IV), for its clinical relevance [21–
23]. Fresh colonies of MRSA were inoculated into tryptic soy broth (TSB) (Thermo Scientific,
Pittsburgh, PA, USA) and grown overnight at 37˚ C. The culture was then resuspended in
fresh broth and grown to mid-log phase for 2 hours. Bacteria were collected by centrifugation,
washed, resuspended in broth, and adjusted to an optical density at 600 nm of 0.5 which corre-
sponds to 106 colony formation units (CFU) per ml of Hanks’ balanced salt solution (HBSS).
Area disinfection assay
Assessment of the ability to diffuse bactericidal far-UVC over an area was performed using the
equipment setup shown in Fig 1. Standard 60-mm diameter plates completely filled
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beforehand with mannitol salt agar (BD Diagnostic System, Sparks, MD, USA) served as the
disinfection surface. A diffuser was suspended in air 1 cm away from the agar surface. One 50-
μl aliquot of 106 CFU/ml of MRSA was spread evenly across the entire agar surface. The laser
was powered for 2 hours to expose the sample and then the dish was incubated overnight to
allow bacteria growth. A second dish was handled in parallel but not exposed to the laser as a
control of the experimental conditions.
Survival assay
Five 5-μl aliquots of 106 CFU/ml of MRSA were dispensed onto a single agar plates as shown
in Fig 1. Each aliquot covered a circular area approximately 5 mm in diameter. Four aliquots
were aligned directly under the length of the diffuser to allow simultaneous exposures while a
fifth aliquot was placed in an unexposed area and used as positive control (i.e. zero UV dose).
All aliquots of bacterial solution were allowed to dry for 30 min and then exposed to the far-
UVC light (or unirradiated in the case of the zero dose). Variation of the far-UVC dose was
obtained by exposing each aliquot for 0.5, 1, 1.5, or 2 h which corresponded to an average far-
UVC dose over the aliquot area of 4.1, 8.1, 12.2, or 16.3 mJ/cm2, respectively. At the end of
each sampling time, a swab of a specific aliquot was taken and resuspended in TSB; 50 μl of
Fig 1. Experimental setup for MRSA area disinfection assay and survival assay. The experimental setup for the
MRSA survival assay includes a far-UVC laser module, a fiber optic cable connecting the laser to an optical diffuser,
and an agar filled petri dish. The diffuser was suspended in air 1 cm above the surface of the agar in the dish. For the
cell survival assay the diffuser was aligned on top of four identical 5-μl aliquots of 106 CFU/ml of MRSA, each with an
area of about 5 mm in diameter. An identical equipment setup was used for the area disinfection assay except 50 μl of
MRSA was spread to cover the entire surface of the dish.
https://doi.org/10.1371/journal.pone.0202275.g001
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serial dilutions were then spread onto tryptic soy agar plates containing 5% sheep blood (BD
Diagnostic System, Sparks, MD, USA) using a Drigalski spatula. Two plates were used for each
exposure condition and were incubated overnight at 37˚ C, with colony counting performed
the following day.
Data analysis
Bacterial survival fraction was expressed as the proportional reduction in CFU/cm2, relative to
unexposed controls for a given experiment. Values represent the average ± SEM of the inde-
pendent experiments. Survival values (S) were calculated for each repeat experiment and
natural log transformed (ln(S)) to bring the error distribution closer to normal [24]. Linear
regression was performed using these normalized ln(S) values as the dependent variable and
UV dose (D, mJ/cm2) as the independent variable. Microorganism susceptibility, i.e. survival
in UV-C light, traditionally follow first-order kinetics and thus the bacterial survival was fitted
to the equation
lnðSÞ ¼   k D; ½Eq 1
with k the UV rate constant or susceptibility factor (cm2/mJ) and D the dose (mJ/cm2) [25].
The regression was performed with the intercept term set to zero, which assumes 100% relative
survival at zero UV dose. Bootstrap 95% confidence intervals for the parameter k were calcu-
lated using R 3.2.3 software [26]. MRSA inactivation cross-section D90, or the UV dose that
kills 90% of the bacteria, was calculated as D90 = − ln (1 − 0.9) / k [25].
Results
Area disinfection assay
The killing of MRSA across a surface is shown in Fig 2. An unmodified picture of the bacteria
plate is shown in the inset of the figure. Dark areas on the figure indicate areas of bacterial
growth. The figure includes an overlay of contour lines which indicate the levels of far-UVC
exposure in mJ/cm2 for the two-hour test as calculated using film dosimetry. The area of high-
est exposure coincides with the area directly beneath the cylindrical diffuser. Less far-UVC
exposure to an area on the surface corresponds to an increase in the amount of MRSA growth.
Irregularities in the exposure pattern are due to physical variations in the diffuser itself that
impacted the uniformity of the diffusion of light.
Survival assay
Fig 3 shows MRSA killing as a function of exposure to far-UVC light generated by a 224-nm
laser and delivered through a diffuser. Raw data of the bacterial counts for each set of experi-
ments and the corresponding log reduction is given in Table 1. The reduction of bacteria sur-
vival followed a classical log-linear UV disinfection model [25], with rate constant k = 0.51
cm2/mJ (standard error = 0.03, R2 = 0.76) with a 95% bootstrapped confidence interval of 0.44
cm2/mJ to 0.57 cm2/mJ. The rate constant corresponds to inactivation cross-sections of D90 =
4.5 mJ/cm2. A line plotting best-fit regression of the inactivation rate is included on Fig 3.
Discussion
This study shows for the first time that far-UVC irradiation delivered using fiber optics is a
promising technology in preventing infections caused by bacterial contamination. Delivery of
a far-UVC light from a laser, through an optical fiber, and emitted from a diffuser is a unique
application of this technology. Assembly of the experimental setup, including an optical fiber
Diffused far-UVC for MRSA disinfection
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and diffuser capable of operating with far-UVC wavelengths, is the first demonstration of a
general approach that could be adapted into various light delivery geometries. The area killing
assay results shown in Fig 2 illustrate that this simple setup using only a single far-UVC laser
source is capable of killing bacteria in vitro over an area much larger than the original laser
beam diameter. The effectiveness of killing MRSA with far-UVC delivered in this manner was
quantified through the survival assay. The disinfection rate constant of 0.51 cm2/mJ, with D90
= 4.5 mJ/cm2, is comparable to surface disinfection studies done on antibiotic-susceptible S.
aureus with germicidal light at 254 nm emitted from a lamp, which had a rate constant
k = 0.72 cm2/mJ with D90 = 3.2 mJ/cm
2 [25]. The difference in performance of the two wave-
lengths for surface disinfection of MRSA is consistent with 254-nm light having a longer pene-
tration distance than the 224-nm light and thus being more effective. Overall, the qualitative
area assay results in Fig 2 displayed general agreement with the quantified survival response
assay results.
Antisepsis using far-UVC light is an exciting option for use directly on and within tissue
because, unlike germicidal UV at 254 nm, it does not produce biological damage to exposed
mammalian cells and tissues. The technology is also unobtrusive, both because of the small
Fig 2. Area of MRSA sterilization after diffused far-UVC exposure. A picture of the MRSA growth pattern after
exposure to diffused far-UVC light shows the ability to sterilize a large area using a single laser source. The MRSA
appears as darker regions against the lighter colored agar. A contour map of the exposure dose, calculated using film
exposures with the same experimental setup and expressed in mJ/cm2, is overlaid to show that variations in dose have a
clear correlation with the killing efficiency. A picture of the dish without doses overlaid is shown in the top right.
https://doi.org/10.1371/journal.pone.0202275.g002
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size and the potential to not require additional protective equipment for the patient or care-
giver, so it could be integrated into existing medical setups with minimal interference to exist-
ing protocols. Additionally, because far-UVC technology works via physical inactivation it is a
potentially powerful tool against drug-resistant bacteria.
Delivery of far-UVC from a laser source using fiber optics is highly applicable to disinfect-
ing difficult geometries. Optical components such as fibers and diffusers are small enough in
size that they can be integrated around and within many of the pieces of medical equipment
that are highly prone to infection. One example application is around a skin penetrating cathe-
ter which could be outfitted with diffusing elements surrounding the cylindrical tubing, thus
providing the bactericidal effects directly at the interface between the skin and the device.
Fiber optics provide the opportunity to use a single laser source to distribute light to numerous
areas using established methods; creative applications of optics would allow for modifying this
technique to fit most medical equipment already in use. These advances in delivery of far-
UVC directly to an infection prone area are necessary because far-UVC wavelengths are
unable to penetrate through most materials including various biological fluids. The lack of
transmission of far-UVC through many biological materials, which is the basis for the indi-
cated safety of this technology, therefore requires unobstructed delivery to target microbes for
effective disinfection.
Recent advances in far-UVC laser technology have shown promise for shrinking both the
size and the cost of the laser module to be better suited for widespread adoption. For example,
Fig 3. MRSA survival fraction for far-UVC exposure doses. Results for the survival assay for the killing of MRSA on
a surface using far-UVC light emitted from a diffuser are plotted as bacterial survival fraction relative to zero-dose
controls for the different exposures. The means and standard errors refer to triplicate repeat studies and the line
represents the best-fit regression to Eq 1. The data follow a log-linear decay with a rate constant of 0.51 cm2/mJ. The
calculated exposure dose required to kill 90% of bacteria is D90 = 4.5 mJ/cm
2.
https://doi.org/10.1371/journal.pone.0202275.g003
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Sharp Laboratories in Europe has produced compact UVC lasers that are about the size of a AA
battery [27]; conversely, the laser module used in this work is 10 cm × 10 cm × 70 cm and 3.6
kg. Smaller laser modules could enable creating disinfection systems with far-UVC technology
that are easily portable and thus able to be applied to a much wider range of applications.
Future work with far-UVC lasers for disinfection would benefit from improved light diffus-
ing technology that is better suited for this application. Because of the difficulty in working
with far-UVC wavelengths, largely due to solarization effects reducing transmittance [25], the
optical components commercially available are limited. New diffusers that were more robust
and more conformable to the unique biological environments that they will be used in would
also advance this technology. Nevertheless, the potential of far-UVC as a safe, effective technol-
ogy that assuages the desire for an antimicrobial tool that functions independent of acquired
drug resistance is worth continued investigation.
Conclusion
This study demonstrates that far-UVC light emitted from a laser and delivered using an optical
diffuser is an effective tool to kill MRSA in vitro. The dose required to kill bacteria on a surface
with far-UVC is slightly higher than with conventional UVC at 254 nm; however, given the
lack of harmful biological effects with far-UVC, it is an attractive option for disinfection within
wounds. The ability to diffuse the laser output over a large area makes this a viable solution for
disinfection of infection prone tissues, such as around a catheter or other skin penetrating
medical device.
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